Board approved audited FY26 results with a 40% YoY rise in net profit and recommended a final dividend of ₹1.50 per share.
Auditors issued a qualified opinion due to unreconciled reinsurance and inter-office balances, with an unascertainable financial impact.
The company absorbed a ₹3,525 crore wage revision impact and reported a solvency ratio of 1.84x, with the incurred claim ratio rising to 98.65%.
Gross written premium grew 8.2% YoY, increasing market share to 12.74%, driven by health segment improvement offset by motor TP losses.